News

Untapped Patient Base, Ingrezza Growth Keep Neurocrine (NBIX) on Guggenheim’s Buy List
Neurocrine Biosciences Inc. (NASDAQ:NBIX) is a leading neuroscience-focused biopharmaceutical company that discovers and ...
Fintel on MSN11h
Guggenheim Initiates Coverage of Digital Realty Trust, Inc. - Preferred Stock (DLR.PRL) with Neutral Recommendation
Fintel reports that on July 10, 2025, Guggenheim initiated coverage of Digital Realty Trust, Inc. - Preferred Stock (NYSE:DLR ...
Football Insider11h
Exclusive: Everton’s Goodison Park move part of plan for major sale – finance expert
Everton's decision not to sell or scrap Goodison Park was part of a longer-term financial plan with a major sale in mind.
10 Canadian historical fiction books to read this summer
Elinor Florence is an author, journalist and member of the Métis Nation of B.C. Her debut novel was Bird's Eye View, and her second novel, Wildwood, was one of Kobo's Hundred Most Popular Canadian ...
Wire 3 Continues to Raise Financing, Accelerating Florida-Focused Growth
Wire 3, a Florida-based, 100% fiber internet provider, announced today that the company has closed on a new private credit ...
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the ...
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock
Soleno Therapeutics, Inc. (Soleno) (Nasdaq:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment ...
The insider secrets to avoiding Venice’s summer crowds
Even at peak visitor periods, the worst excesses can be avoided and you’re never more than a bridge away from secluded Venice ...